We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Orgenesis Inc | NASDAQ:ORGS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.039 | -6.45% | 0.5657 | 0.4603 | 0.5663 | 0.6349 | 0.5582 | 0.62 | 14,976 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 22, 2016
ORGENESIS INC.
(Exact name
of registrant as specified in its charter)
Nevada
|
000-54329
|
98-0583166
|
(State or other
|
(Commission File
|
(IRS Employer
|
jurisdiction
|
Number)
|
Identification No.)
|
of incorporation
|
|
|
20271 Goldenrod Lane, Germantown, MD 20876
(Address of principal executive offices) (Zip Code)
Registrants telephone number, including area code: (480) 659-6404
Not Applicable
(Former name or former
address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
Item 1.01 Entry into a Material Definitive Agreement
The information included in Item 3.02 of this Form 8-K is hereby incorporated by reference into this Item 1.01.
Item 3.02. Unregistered Sales of Equity Securities.
On December 22, 2016, Orgenesis Inc. (the Company) entered into a definitive agreement with an investor (the Investor) relating to a private placement (the Private Placement) of units of the Companys securities (the Units) for aggregate subscription consideration to the Company of $15,000,000. The Units are comprised of (i) 28,846,154 shares (the Shares) of the Companys common stock par value $0.0001 per share (the Common Stock) and (ii) three year warrants (the Warrants) to purchase an additional 28,846,154 shares of Common Stock at per share exercise price of $0.52. Payment by the Investor of the subscription amount and the issuance of the Shares and Warrants will be made following the (i) formation in India of an entity through which certain joint venture activities, which are currently the subject of negotiations between the Company and affiliates of the Investor, are to be carried out and (ii) establishment of banking credit and other facilities through which the subscription amount can be transferred to the Company.
The issuance of the Shares and Warrants will be exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, for transactions not involving a public offering provided by Regulation S promulgated under the Securities Act of 1933, as amended (the Securities Act). The Companys reliance on Regulation S was based on the fact that Investor is not a U.S. person as that term is defined in Rule 902(k) of Regulation S, that it is acquiring the securities for investment purposes for its own account and not as nominee or agent, and not with a view to the resale or distribution thereof, and that the Investor understand that the securities may not be sold or otherwise disposed of without registration under the Securities Act and any applicable state securities laws, or an applicable exemption or exemptions therefrom.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ORGENESIS INC.
By:
/s/ Neil Reithinger | |
Neil Reithinger | |
Chief Financial Officer, Treasurer and Secretary | |
December 23, 2016 |
3
1 Year Orgenesis Chart |
1 Month Orgenesis Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions